Skip to main content
. Author manuscript; available in PMC: 2020 Sep 24.
Published in final edited form as: J Urol. 2016 Jan 23;195(6):1737–1743. doi: 10.1016/j.juro.2015.12.102

Table 1.

Overall patient characteristics and biopsy outcomes at vs outside NCI

Mean Before Matching
Mean After Matching
NCI Outside Difference p Value NCI Outside Difference p Value
No. pts 620 310 510 310
Age 62.1 65.4 3.2 <0.0001 65.6 65.4 −0.2 0.7328
PSA (ng/ml) 11.9 10 −1.9 0.5437 10.4 10 −0.5 0.5521
% Suspicion: <0.0001 0.9543
 Low 11 6.5 −4.5 6.2 6.5 0.3
 Moderate 70.6 88.7 18.1 89.4 88.7 −0.7
 High 18.4 4.8 −13.5 4.4 4.8 0.4
% Prior neg biopsy 68.5 60 −8.5 0.0119 64.6 60 −4.6 0.2343
% CDR:
 By FB 40 53.2 13.2 0.0002 39.1 53.2 14.2 0.0054
 By SB + FB 47.3 64.5 17.3 <0.0001 47.2 64.5 17.3 0.0004
% Upgrading:
 By FB 38.2 33 −5.2 0.2754 26.1 33 6.9 0.2701
 By random biopsy 22.2 29.5 7.3 0.0832 32.3 29.5 −2.8 0.6829
 Clinically significant* by FB 21.2 20.5 −0.7 0.9487 17.5 20.5 3 0.5987
 Clinically significant* by SB 6.8 9.5 2.7 0.3627 14.7 9.5 −5.2 0.244
*

Defined as Gleason 3 + 4 = 7 or greater.